Palvella Therapeutics PVLA Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -34.2%+57.8pp | -92.1%— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 28.9×+23.7× | 5.2×-1.3× | 6.5×-1.2× | 7.7×-1.2× | 8.8×+1.5× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $17.75+614% | $2.49-28.9% | $3.50-19.1% | $4.32-14.3% | $5.05-82.1% | |
| Valuation | ||||||
| Market capitalization | $1.78B+44.0% | $1.24B+78.7% | $693.33M+184% | $243.89M-22.3% | $314.08M+133% | |
| Price / book | 7.7×-36.6× | 44.3×+26.4× | 17.9×+12.8× | 5.1×-0.5× | 5.7×+3.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Palvella Therapeutics's ratios come from?
- Every ratio is computed from Palvella Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.